Startseite Crystal structure of 11-(p-coumaroyloxy)-tremetone, C22H20O5
Artikel Open Access

Crystal structure of 11-(p-coumaroyloxy)-tremetone, C22H20O5

  • Iván Brito EMAIL logo , Mario Simirgiotis , Rubén Muñoz , Julio Benites , Leyla Pasten , Jorge Bórquez und Alejandro Cárdenas
Veröffentlicht/Copyright: 1. Oktober 2016

Abstract

C22H20O5, orthorhombic, P212121 (no. 19), a = 6.2039(3) Å, b = 13.1634(8) Å, c = 22.8258(12) Å, V = 1864.06(17) Å3, Z = 4, Rgt(F) = 0.053, wRref(F2) = 0.117, T = 297(2) K.

CCDC no.:: 1504400

The title crystal structure (sytematic name: 2-(5-acetyl-2,3-dihydrobenzofuran-2-yl)allyl (E)-3-(4-hydroxyphenyl)acrylate) is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.

Table 1

Data collection and handling.

Crystal:Colorless block Size 0.16 × 0.12 × 0.05 mm
Wavelength:Cu Kα radiation (1.54178 Å)
μ:7.5 cm−1
Diffractometer, scan mode:Bruker AXS, φ and ω
2θmax, completeness:117.2°, >99%
N(hkl)measured, N(hkl)unique, Rint:15024, 2635, 0.141
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 1638
N(param)refined:247
Programs:SHELX [4], Bruker programs [5], OLEX2 [6]
Table 2

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O10.5954(6)0.8931(4)0.45813(15)0.0791(13)
H10.68890.87170.43600.119*
O21.0292(8)0.8641(4)0.80724(17)0.0880(15)
O30.6975(6)0.8804(3)0.84272(14)0.0617(10)
O40.7176(6)0.6537(3)0.89249(15)0.0672(12)
O50.3260(8)0.6486(3)0.63958(16)0.0854(14)
C4′0.6638(11)0.8836(4)0.5149(2)0.0615(15)
C3′0.8588(10)0.8447(4)0.5300(2)0.0678(17)
H20.95230.82090.50130.081*
C2′0.9176(10)0.8405(5)0.5888(2)0.0701(17)
H31.05240.81500.59880.084*
C1′0.7814(10)0.8733(4)0.6325(2)0.0542(14)
C6′0.5837(11)0.9113(4)0.6158(3)0.0678(17)
H50.48760.93360.64430.081*
C5′0.5261(10)0.9169(4)0.5577(3)0.0710(19)
H60.39250.94350.54730.085*
C7′0.8508(10)0.8678(4)0.6933(2)0.0592(16)
H70.99400.84920.69890.071*
C8′0.7404(10)0.8855(4)0.7417(2)0.0597(15)
H80.59620.90420.73920.072*
C9′0.8418(13)0.8760(4)0.7987(2)0.0603(16)
C110.7824(10)0.8662(5)0.90185(19)0.0656(17)
H10A0.81670.93160.91910.079*
H10B0.91320.82600.90040.079*
C100.6163(9)0.8133(4)0.9381(2)0.0557(16)
C120.5509(9)0.8530(5)0.9876(2)0.0754(19)
H12A0.60790.91451.00040.090*
H12B0.44760.81971.01000.090*
C20.5377(9)0.7112(4)0.9176(2)0.0611(16)
H130.48170.67380.95140.073*
C30.3616(9)0.7145(5)0.8699(2)0.0681(18)
H14A0.23940.67240.88040.082*
H14B0.31220.78340.86310.082*
C3A0.4764(10)0.6730(4)0.8169(2)0.0535(15)
C40.4174(10)0.6657(4)0.7592(2)0.0579(15)
H160.28320.68900.74690.069*
C50.5606(10)0.6230(4)0.7190(2)0.0562(15)
C60.7595(12)0.5894(4)0.7383(3)0.0695(18)
H180.85360.56040.71130.083*
C70.8242(10)0.5975(4)0.7965(3)0.0682(17)
H190.95910.57560.80900.082*
C7A0.6769(10)0.6397(4)0.8343(2)0.0566(15)
C80.5002(11)0.6152(5)0.6567(2)0.0677(18)
C90.6516(11)0.5689(5)0.6135(2)0.089(2)
H22A0.57940.56050.57660.133*
H22B0.69840.50380.62760.133*
H22C0.77420.61250.60850.133*

Source of material

The title compound C22H20O5 was isolated using medium pressure column chromatography. Dried aerial parts of Parastrephia quadrangularis (1622 g) collected in april 2015 in El Tatio, Atacama Desert, Northern Chile were defatted with hexane (3 liters, 3 times in the dark, 24 Hr each time) and 54.82 g were obtained after evaporation of the solvent. Then the plant material was extracted with ethyl acetate (3 liters, 3 times in the dark, 24 Hr each time. After evaporation of the solvent under vacuo at 35 oC, 485 g of a dark gummy extract was obtained. A portion of the extract (16 g) was filtered and submitted to a medium pressure column chromatography system composed of an 2.5 cm x 48 cm medium pressure column (Aceglass inc, Vineland, NY, USA) packed with silicagel (Kieselgel 60 H, Merck, Darmstadt, Germany) using an isocratic solvent system of hexane-ethyl acetate (8:2 v:v) pumped with a medium pressure pump (FMI lab pump, Syosset, NY, USA) with a flow rate of 10 mL-minute. The fractions were collected using a Gilson FC 203B fraction collector (Gilson, Middleton, MI, USA) and the volume of each fraction was 5 mL·The collected fractions (140) were combined according to TLC analysis (Kieselgel F254 plates, developed with CHCl3: EtOAc 18:2 v/v, and spots visualized by spraying with vanillin: sulfuric acid 2% in ethanol and heating) and 17 combined fractions were obtained. Fraction eight (1.5 g) was re-chromatographed using the same system and 22 mg of umbelliferone [1] were isolated. Fraction 11 (3.5 g) was chromatographed using the mentioned system and the title compound [2] was isolated (525 mg). Suitable crystals for a crystallographic study were obtained after re-crystallization from hexane: ethyl acetate 9:1 v/v. The structure was already reported, however, we have revised and corrected NMR data [1] with the help of detailed two-dimensional NMR spectra (DEPT, COSY, HMBC and HMQC). Analysis: colourless crystals, m.p. 124–125 oC (Stuart Scientific SMP3 melting point apparatus, Bibby Scientific Ltd, Staffordshire, UK), HRESIMS (Q exactive focus, Thermo Fischer inc, Bremen, Germany), Found: 363.1308 [M—H] calculated for C22H19O5: 363.1310.

Experimental details

H atoms were located in the difference Fourier map, but refined with fixed individual displacement parameters, using a riding model with C—H distances of 0.93 Å (for aromatic rings), 0.96 Å (for CH3), with U(H) values of 1.2Ueq(C) (for CH in aromatic moiety), and 1.5Ueq(C) (for methyl), O—H distances are 0.82 Å with U(H) = 1.5Ueq(O).

Discussion

Due to exocyclic double bond, the p-cumaric acid and tremetone fragments make angle of 11.33(16)°. The crystal packing is stabilized by intermolecular O—H⋯O hydrogen bonds, between hydroxyl and carbonyl groups O(1)—H(1)⋯O(5)i [symmetry code: (i) 1/2 + x, 3/2 − y, 1 − z] which links the molecules into chains with graph-set notation C(16) [3] running along the b axis [100]. All distances and angles are in the normal range. All proton NMR spectroscopic evidence was similar to that previously published [2].

Acknowledgements

The authors thank fondecyt (Grant 1140178) and fondequip (EQM14002) for financial support. IB Thanks to fondequip (EQM13–0021).

References

1. Pan, L.; Li, X.-Z.; Yan, Z.-Q.; Guo, H.-R.; Qin, B.: Phytotoxicity of umbelliferone and its analogs: Structure–activity relationships and action mechanisms. Plant Physiol. Biochem. 97 (2015) 272–277.10.1016/j.plaphy.2015.10.020Suche in Google Scholar

2. Bohlmann, F.; Fritz, U.; King, R. M.: Neue tremeton-derivate aus Parastrephia lepidophylla. Phytochemistry 18 (1979) 1403–1405.10.1016/0031-9422(79)83037-XSuche in Google Scholar

3. Bernstein, J.; Davis, R. E.; Shimoni, L.; Chang, N.-L.: Patterns in hydrogen bonding: functionality and graph set analysis in crystals. Angew. Chem. Int. Ed. 34 (1995) 1555–1573.10.1002/anie.199515551Suche in Google Scholar

4. Sheldrick, G. M.: SHELXT-Integrated space-group and crystal-structure determination. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053273314026370Suche in Google Scholar PubMed PubMed Central

5. Bruker. APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA, 2007.Suche in Google Scholar

6. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Cryst. 42 (2009) 339–341.10.1107/S0021889808042726Suche in Google Scholar

Received: 2016-6-28
Accepted: 2016-9-14
Published Online: 2016-10-1
Published in Print: 2017-1-1

©2016 Iván Brito et al., published by De Gruyter.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Editorial
  3. Twenty years of crystal structure publication and the road ahead
  4. Crystal Structures
  5. Crystal structure of poly-[triaqua-(μ4-5′-carboxy-[1,1′-biphenyl]-2,3,3′-tricarboxylate-κ6O1,O2:O3,O4:O5:O6)praseodymium(III), C16H13O11Pr
  6. Crystal structure of (R)-1-(2,3-dihydro-1H-pyrrolizin-5-yl)-2,3-dihydroxypropan-1-one, C10H13NO3
  7. Crystal structure of (E)-4-nitro-2-((2-phenoxyphenylimino)methyl)phenol, C19H14N2O4
  8. Crystal structure of 3,3′-di(furan-2-yl)-5,5′-bi-1,2,4-triazine
  9. Crystal structure of 11-(p-coumaroyloxy)-tremetone, C22H20O5
  10. The crystal structure of 1,3-bis(2,6-diiso-propylphenyl)imidazol-2-ylidene)-dibromido-(1-methyl-1H-imidazole-κ1N)palladium(II) – ethyl acetate – water (1/1/1), C31H42Br2N4Pd
  11. Crystal structure of 2-((3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-1H-indene-1,3(2H)-dione, C28H19N5O2
  12. Crystal structure of 2-(5-(4-fluorophenyl)-3-p-tolyl-4,5-dihydro-1H-pyrazol-1-yl)-4-(5-methyl-1-p-tolyl-1H-1,2,3-triazol-4-yl)thiazole, C29H25FN6S
  13. Crystal structure of poly-[aqua-(μ7-benzene-1,3,5-tricarboxylato)-(μ3-1,2,4-triazol-1-ido)dicobalt(II)], C11H7Co2N3O7
  14. Crystal constructure of 16(S)-methyl-6α-carboxy-1, 15-dioxo-6, 7-seco-ent-kaur-2-en-7, 20-olide, C20H24O6
  15. Crystal structure of 1-(benzo[d]thiazol-2-yl)-3-phenylthiourea, C14H11N3S2
  16. Crystal structure of 3-(2-bromophenyl)-1,1-dimethylthiourea, C9H11BrN2S
  17. Crystal structure of 1-(adamantan-1-yl)-3-(3-chlorophenyl)thiourea, C17H21ClN2S
  18. Crystal structure of 3-(adamantan-1-yl)-1-(4-bromophenyl)urea, C17H21BrN2O
  19. Crystal structure of (Z)-Ethyl 2-cyano-2-(3-phenylthiazolidin-2-ylidene) acetate, C14H14N2O2S
  20. Crystal structure of methyl 2b-ethyl-1a,2a,2b,2b1,3,5,10,11-octahydro-1H-oxireno[2′,3′:6,7]indolizino[8,1-cd]carbazole-4-carboxylate, C21H24N2O3
  21. Crystal structure of 2-amino-5-oxo-4-(3,4,5-trimethoxy-phenyl)-4,5,6,7-tetrahydro-cyclopenta[b]pyran-3-carbonitrile, C18H18N2O5
  22. Crystal structure of 1,2,3-trimethyl-2,3-dihydro-1H-perimidine, C14H16N2
  23. Crystal structure of bis(2,6-dihydroxymethyl)pyridine-κ3N,O,O′)-bis(μ2-6-chloropyridin-2-olato-κ3N,O:O)-bis(6-chloropyridin-2-olato-κO)-bis(nitrato-κ2O,O′)digadolinium(III), C34H30Cl4Gd2N8O14
  24. Crystal structure of 8-isopropyl-8-aza-bicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate, C19H27NO3
  25. Crystal structure of 1-methyl-3-[((naphthalen-2-ylsulfonyl)oxy)imino]indolin-2-one, C19H14N2O4S
  26. Crystal structure (7,8-bis(diisopropylphosphino)-7,8-dicarba-nido-undecaborane-κ2P,P′)-(benzoato-κ2O,O′)nickel(II), C21H42B9NiO2P2
  27. Crystal structure of methyl-2-methyl-4-(2-oxo-2-phenylethyl)-5-phenyl-1H-pyrrole-3-carboxylate, C21H19NO3
  28. Crystal structure of 2-[(2-oxo-thiazolidine-3-carbonyl)sulfamoyl]-methy-benzoic acid methyl ester, C13H14N2O6S2
  29. Crystal structure of N′-(2-phenylacetyl)thiophene-2-carbohydrazide monohydrate, C13H14N2O3S
  30. Crystal structure of 1,1′-(hexane-1,6-diyl)bis(3-methyl-1H-imidazol-3-ium) bis(hexafluoro phosphate), C14H24F12N4P2
  31. Crystal structure of di-μ-chlorido-bis[1,2-bis(dicyclohexylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]zinc(II), C52H108B20Cl2P4Zn2
  32. Crystal structure of dibromido-bis[μ-1-[(2-methyl-1H-benzoimidazol-1-yl)methyl]-1H-benzotriazole-κN]mercury(II), C30H26Br2HgN10
  33. Crystal structure of bis(μ-nitrato-κ2O:O)-bis[1,2-bis(diphenylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]disilver(I) dicloromethane monosolvate, C54H64B20Cl4O6P4Ag2
  34. Crystal structure of dinuclear dichloridobis(dimethylformamide-kO)bis[μ2-3-(2-oxyphenyl)-5-(pyrazin-2-yl)-1,2,4-triazol-1ido-κ4-O,N:N′,N′′(2)]diiron(III) dimethylformamide (1/1), C36H42Cl2Fe2N14O6
  35. Crystal structure of diaqua-dinitrato-κO-bis(4-(1H-pyrazol-3-yl)pyridine-κN)manganese(II), C16H18MnN8O8
  36. Crystal structure of (Z)-6-methoxy-2-(2,2,2-trifluoro-1-hydroxyethylidene)-2,3-dihydro-1H-inden-1-one, C12H6F6O3
  37. Crystal Structure of 4-(2-chloroacetamido)pyridinium chloride monohydrate, C7H10Cl2N2O2
  38. Crystal structure of 2-amino-4-(4-chloro-phenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H13ClN2O2
  39. Crystal structure of (E)-1-(2-(thiophen-2-ylmethylene)hydrazinyl)phthalazine hydrochloride–ethanol (1/1), C15H17ClN4OS
  40. Crystal structure of N,N-diethyl-5-bromo-3,4-dihydro-2,4-dioxopyrimidine-1(2H)-carboxamide, C9H12BrN3O3
  41. Crystal structure of 3-(2-(4-chlorophenyl)-3-hydroxy-3,3-diphenylpropyl)-1,1-dimethylurea, C24H25ClN2O2
  42. Crystal structure of 3-(4-chlorophenyl)-1,1-dimethylthiourea, C9H11ClN2S
  43. Crystal structure of 2-amino-4-(4-bromo-phenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile, C16H11BrN2O3
  44. Crystal structure of 4-(3,4-dimethyl-phenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid ethyl ester, C21H25NO3
  45. Crystal structure of (E)-2-({4-hydroxy-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]phenyl} methylidene)-1-indanone, C23H26N2O3
  46. Crystal structure of tripropylammonium 2′-carboxy-[1,1′-biphenyl]-2-carboxylate – [1,1′-biphenyl]-2,2′-dicarboxylic acid (2/1), C60H72N2O12
  47. Crystal structure of catena-poly-{aqua-[μ2-1,2-bis((1H-imidazol-1-yl)methyl)benzene-κ2N:N′]-[μ2-4,4′-(dimethylsilanediyl)dibenzato-κ3O,O′:O′]nickel(II)}, C30H30N4NiO5Si
  48. The crystal structure of 1-(4-bromophenyl)-2-(4-(4-fluorophenyl)piperazin-1-yl)ethanol, C18H20BrFN2O1
  49. Crystal structure of trimethylammonium 4-((4-carboxyphenyl)sulfonyl)benzoate, C17H19NO6S
  50. Crystal structure of syn-2,4-di-o-tolylpentane-2,4-diol, C19H24O2
  51. Crystal structure of 2-[3,5-bis(trifluoromethyl)benzylsulfanyl]-5-(5-bromothiophen-2-yl)-1,3,4-oxadiazole, C15H7BrF6N2OS2
  52. Crystal structure of (E)-3-((naphthalen-1-ylimino)methyl)-4-nitrophenol, C17H12N2O3
  53. Crystal structure of 2-dichloromethyl-2-p-nitrophenyl-1,3-dioxolane, C10H9Cl2NO4
  54. Crystal structure of (1,4,8,11-tetraazacyclotetradecane)palladium(II) tetracyanopalladate(II), C14H24N8Pd2
  55. Crystal structure of 2-(4-oxo-2-thioxothiazolidin-3-yl)acetic acid monohydrate, C5H7NO4S2
  56. Crystal structure of a P4-bridged (η5-pentamethyl-cyclopentadienyl)(η5-adamantylcyclopentadienyl) titanium(III)complex, C50H66P4Ti2
  57. Crystal structure of cis-bis(2,2′-bipyrimidine-κ2N,N′)bis(thiocyanato-κN)nickel(II), C18H12N10NiS2
  58. Crystal structure of cis-bis(2,2′-bipyridine-κ2N,N′)dibromidomanganese(II), C20H16Br2MnN4
  59. Crystal structure of cis-bis(2,2′-bipyridine-κ2N,N′)bis(thiocyanato-κN)nickel(II), C22H16N6NiS2
  60. Crystal structure of trans-dibromido(1,4,8,11-tetraazacyclotetradecane)nickel(II), C10H24Br2N4Ni
  61. Crystal structure of cis-tetrabromidobis(pyridine-κN)platinum(IV), C10H10Br4N2Pt
  62. Crystal structure of (E)-5-((4-chlorophenyl)diazenyl)-2-(5-(4-fluorophenyl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole, C23H17ClFN5S2
  63. The crystal structure of 3-((1R,2S)-1-methylpyrrolidin-1-ium-2-yl)pyridin-1-ium tetrachloridocobaltate(II) monohydrate, C10H18Cl4CoN2O
Heruntergeladen am 19.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2016-0105/html
Button zum nach oben scrollen